Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Kei Hosoya, Taro Komachi, Katsunori Masaki, Isao Suzaki, Hidehisa Saeki, Naoko Kanda, Makoto Nozaki, Yosuke Kamide, Yoshinori Matsuwaki, Yoshiki Kobayashi, Eriko Ogino, Shin-Ichi Osada, Norihiro Usukura, Toshikazu Kurumagawa, Junya Ninomia, Mikiya Asako, Keitaro Nakamoto, Hidenori Yokoi, Manabu Ohyama, Keiji Tanese, Sho Kanzaki, Koichi Fukunaga, Motohiro Ebisawa & Kimihiro Okubo. (2023) Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study. Patient Preference and Adherence 17, pages 861-872.
Read now
Read now
Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Read now
Yan Wei, Jin Zhao, Jian Ming, Xuewu Zhang & Yingyao Chen. (2022) Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China. Patient Preference and Adherence 16, pages 2387-2398.
Read now
Read now
Steven R. Feldman, Christine Poulos, Isabelle Gilloteau, Brennan Mange, Katharina Boehm, Marco Boeri, Mandy Naatz & Matthias Augustin. (2022) Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany. Journal of Dermatological Treatment 33:3, pages 1511-1520.
Read now
Read now
Jean-David Zeitoun & Yves Morvan. (2020) Patients’ Perceptions and Preferences Regarding Two Different Forms of Methotrexate Autoinjectors for Moderate to Severe Rheumatoid Arthritis: A European Crossover Survey. Patient Preference and Adherence 14, pages 2177-2185.
Read now
Read now
Peita L Graham-Clarke, Brett Hauber, Marco Boeri, Felice Leonardi, Russel T Burge, Maria Fernandez, Antje Tockhorn-Heidenreich & Sandra Florez. (2020) Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia. Patient Preference and Adherence 14, pages 1049-1064.
Read now
Read now
Andreas Schneider, Philippe Mueller, Christoph Jordi, Philipp Richard, Peter Sneeringer, Ranjan Nayyar, Mary Yovanoff & Jakob Lange. (2020) Hold the device against the skin: the impact of injection duration on user’s force for handheld autoinjectors. Expert Opinion on Drug Delivery 17:2, pages 225-236.
Read now
Read now
Naceur Rekaya, Alexandra Pickersgill & Louisa Harvey. (2019) Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis. Medical Devices: Evidence and Research 12, pages 443-450.
Read now
Read now
Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Rainard Fuhr, Thomas Koernicke, Ellen Schuck, Maria Velinova, Andrej Skerjanec, Johann Poetzl & Julia Jauch-Lembach. (2019) GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods. Expert Opinion on Biological Therapy 19:10, pages 1075-1083.
Read now
Read now
Articles from other publishers (11)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T. Muriset, David Gruben & Mark Latymer. (2023) High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and Therapy 10:2, pages 477-487.
Crossref
Crossref
Amy Perrin Ross, Christian Besser, Shubhanvita Naval, Dee Stoneman, Harriet Gaunt & Noreen Barker. (2023) Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey. BMC Neurology 23:1.
Crossref
Crossref
Beate Bittner. (2023) Customer-centric product presentations for monoclonal antibodies. AAPS Open 9:1.
Crossref
Crossref
Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman & Jan Marsal. (2022) Real‐world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 55:11, pages 1389-1401.
Crossref
Crossref
Sara Eileen Meyer, Juliana Rachel Hoeper, Jens Buchholz & Dirk Meyer-Olson. (2022) Technische Alltagshilfen in der Rheumatologie – Was ist
sinnvoll, was ist bewiesen, welche Perspektiven gibt es?. Aktuelle Rheumatologie 47:01, pages 33-42.
Crossref
Crossref
Helen Tyrrell, Renato Ravanello, Jennifer Pulley, Meina Tao Tang, Wenhui Zhang, Mariam Abouhossein & Swati Tole. (2021) An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers. Advances in Therapy 38:5, pages 2406-2417.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
159
179
.
Naceur Rekaya, Steven M. Vicik, Bors T. Hulesch & Laura L. McDonald. (2020) Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits. Rheumatology and Therapy 7:3, pages 537-552.
Crossref
Crossref
Brigitte Delemer, Thierry Nguyen-Tan-Hon, Romain Coriat, Denis Smith, Frank Schillo, Isabelle Raingeard, Iradj Sobhani, Pierre-Luc Etienne, Benedicte Decoudier, Ségolène Bisot-Locard, Alexandre Santos, Gerald Raverot & Guillaume Cadiot. (2020) Evaluation of Nurses’ and Patients’ Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study. Advances in Therapy 37:9, pages 3901-3915.
Crossref
Crossref
Hanna M Tolonen, Marja SA Airaksinen, Päivi Ruokoniemi, Katri Hämeen-Anttila, Kenneth M Shermock & Pekka Kurki. (2019) Medication safety risks to be managed in national implementation of automatic substitution of biological medicines: a qualitative study. BMJ Open 9:10, pages e032892.
Crossref
Crossref
Steve Fenwick, Kunal Thakur & Duncan Munro. (2019) Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey. Rheumatology and Therapy 6:2, pages 195-206.
Crossref
Crossref